See inside every stock. Pro
S&P 5007,624▼ 0.52%Nasdaq25,955▼ 0.21%Dow Jones52,215▼ 1.23%Nasdaq 10028,958▼ 0.00%VIX19.45▲ 2.21%US Dollar101.75▲ 0.14%Gold spot3,994▼ 0.75%WTI103.27▲ 3.82%
London Exchange · UK · Updated after 23 Oct 2026 close

Oxford BioMedica PLC

OXB · London Exchange · prices in GBX
GBX 514.00▲ +3.00 (0.59%)
Research reportHistorical data

About Oxford BioMedica PLC

Oxford BioMedica is a biopharmaceutical company based in Oxford, England, that works in gene and cell therapy. It develops treatments that use modified viruses to deliver genes into patients' cells, and it also makes these viral vectors for other drug developers. Its customers include pharmaceutical and biotechnology companies that need clinical and commercial supplies of vectors, and its own pipeline has addressed conditions such as Parkinson's disease and inherited eye disorders.

The shares are listed on the London Exchange in UK under the code OXB, and the price on this page is in pence sterling (GBX). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

32/ 100
Market X-Ray · price-based
Weak price profile
Ranks #2999 of 3787 on the London Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendWeak
15/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-16.0%
From 52-week high-43.7%
MomentumWeak
21/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-12.0%
6-month return-19.3%
12-month, skipping last month-18.8%
Stability (higher is calmer)Weak
22/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)50.5%
Worst drawdown, 1 year (smaller is calmer)-53.6%
LiquidityStrong
94/100
Trades actively.
See the numbers →
Avg daily value traded358.88M GBX
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
Price trend
Below its 200-day average
Versus its 50- and 200-day averages
52-week range
420.00 – 962.00
Price is 17% of the way up
Returns
−12.0% 3m · −13.2% 1y
Price returns, dividends not included
RSI (14)
51
Neutral zone

Price chart

52-wk range 420.00 – 962.00 Daily closes, split-adjusted

Signals

50-day average493.94
200-day average612.17
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)24.44

Technical summary

Daily
Bearish
4 bullish · 4 neutral · 8 bearish
Weekly
Bearish
3 bullish · 1 neutral · 8 bearish
Monthly
Bearish
2 bullish · 1 neutral · 5 bearish
Moving averages (daily)
SMA 10517.1Bearish
EMA 10516.5Bearish
SMA 20520.1Bearish
EMA 20512.8Bullish
SMA 50493.9Bullish
EMA 50513.4Bullish
SMA 100543.9Bearish
EMA 100536.7Bearish
SMA 200612.2Bearish
EMA 200559.3Bearish
Oscillators (daily)
RSI (14)51.29Neutral
MACD (12, 26)5.34Bullish
Momentum (12)-2.65Bearish
Stochastic %K (14)29.50Neutral
Williams %R (14)-70.50Neutral
CCI (20)-19.34Neutral
Pivot points (classic, last session)
S3
464.3
S2
484.7
S1
499.3
Pivot
519.7
R1
534.3
R2
554.7
R3
569.3
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.

Prices are end-of-day closes in GBX. Educational only, not financial advice.